BioSpace News Archive

ThermoGenesis Holdings, Inc. (Nasdaq: THMO) today announced that it has received notification from the United States Patent and Trademark Office (USPTO) of its intent to issue U.S. Patent No. 10,823,746 on November 3 , for the Company’s new breakthrough lateral flow immunoassay test reader technology, the ThermoGenesis Rea

Lyndra Therapeutics , a clinical-stage biotech company working to make daily pills a thing of the past, today announced the appointment of George Eldridge as Chief Financial Officer. As a seasoned industry veteran, Mr. Eldridge brings with him 27 years of experience leading biotechnology and life sciences companies in both the

- Contribution of up to $2.8 million will support clinical advancement of bacTRL-Spike™ oral vaccine candidate - Proprietary bacTRL™ platform can be used to produce vaccines that can be stored at room temperature and administered orally rather than injected

Ymir Genomics LLC (Ymir) and the Oregon Health & Science University (OHSU) Knight Cancer Institute today announced a licensing agreement and filed patent application that seeks to protect and promote newly-discovered high value urinary biomarkers for detecting cirrhosis and/or hepatocellular carcinoma (HC

The Doc, LLC. (the “Company”) today announced the development of a new rapid detection serological antibody test kit for SARS-CoV-2, the virus that causes COVID-19.